Novartis first-in-class Cosentyx (secukinumab) approved in China for psoriasis patients April 2, 2019https://www.globenewswire.com/news-release/2019/04/02/1794808/0/en/Novartis-first-in-class-Cosentyx-approved-in-China-for-psoriasis-patients.html
